Last checked at 7 Aug 2009 15:39
NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS
This form is intended for use by an issuer to make a RIS notification required by DR 3.1.4R(1).
(1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24. (2) An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24. (3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24. (4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
PLEASE COMPLETE ALL RELEVANT BOXES IN BLOCK CAPITAL LETTERS.
1. Name of the issuer:
FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC
2. State whether the notification relates to:
i. a transaction notified in accordance with DR 3.1.4R(1)(a); or
(ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; or
(iii) both (i) and (ii)
(iii) BOTH (i) AND (ii)
3. Name of person discharging managerial responsibilities/director:
PROFESSOR DUNCAN GEDDES
4. State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person:
AS IN 3 ABOVE
5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest:
AS IN 3 ABOVE
6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares:
ORDINARY 25p SHARES
7. Name of registered shareholders(s) and, if more than one, the number of shares held by each of them:
NOT STATED
8. State the nature of the transaction:
ACQUISITION
9. Number of shares, debentures or financial instruments relating to shares acquired:
4,000 ORDINARY SHARES
10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage):
0.008%
11. Number of shares, debentures or financial instruments relating to shares disposed:
NOT APPLICABLE
12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage):
NOT APPLICABLE
13. Price per share or value of transaction:
464.00p PER SHARE
14. Date and place of transaction:
5 AUGUST 2009 15. Total holding following notification and total percentage holding followingnotification (any treasury shares should not be taken into account whencalculating percentage):42,250 ORDINARY SHARES 0.09%
16. Date issuer informed of transaction:
5 AUGUST 2009
If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes
17. Date of grant:
-
18. Period during which or date on which it can be exercised:
-
19. Total amount paid (if any) for grant of the option:
-
20. Description of shares or debentures involved (class and number):
-
21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise:
-
22. Total number of shares or debentures over which options held following notification:
-
23. Any additional information:
THE PURCHASE AROSE OUT OF AN EXERCISE OF 4,000 WARRANTS IN THE COMPANY AT AN EXERCISE PRICE OF 464P PER SHARE.
24. Name of contact and telephone number for queries:
MARK POPE, COMPANY SECRETARY TEL: 020 3 008 4913 Name and signature of duly authorised officer of issuer responsible for makingnotification: MARK POPE Date of notification:7 AUGUST 2009 - END -
vendor